Polaris Market Research presents its latest market research report, titled Leukapheresis Market Share, Size, Trends, Industry Analysis Report, 2026-2034. It is a comprehensive market research report analyzing the fast-evolving Leukapheresis Market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The study is a combination of qualitative and quantitative analysis, giving insights about the size of the market, segments, regional performance, and industry developments. By going through the report, stakeholders can get an in-depth overview of the Leukapheresis Market and its outlook during the forecast period.
Leukapheresis Market Key Takeaways
- The Leukapheresis Market size was valued at USD 93.09 million in 2025.
- The market is estimated to reach USD 199.38 million by 2034.
- The market is projected to witness a CAGR of 8.8% from 2026 to 2034.
- The devices segment held the largest share of the market in 2025.
- The research application segment is likely to witness the highest CAGR during the forecast period.
- The North America region held the largest share of market revenue in 2025.
- The Asia Pacific region is expected to be the fastest-growing region from 2026 to 2034.
What is Leukapheresis Market?
The Leukapheresis Market covers devices and disposables used to separate white blood cells from blood for therapeutic and research purposes. It supports leukemia treatment, hyperleukocytosis management, and the collection of leukopaks and PBMCs used as starting material for cell and gene therapies, including CAR-T cell manufacturing.
Market Dynamics
The report examines the key market dynamics influencing the growth and development of the Leukapheresis Market. It analyzes the market drivers, market opportunities, market trends, and restraints that might impact the growth of the market.
Key Market Driver: Rising Incidence and Prevalence of Leukemia
The growing global incidence of leukemia, driven by an aging population, environmental factors, and lifestyle changes, is a primary driver of the Leukapheresis Market. More patients are being diagnosed each year and living longer with chronic or relapsing disease, increasing demand for leukocyte reduction and white cell procurement. This is especially true in acute and aggressive leukemia cases, where leukapheresis is a critical procedure for rapidly reducing circulating blasts and preventing complications of leukostasis.
Market Opportunity: Advancements in Automation and Closed-System Technologies
Advancements in automation, closed-system processing, and improved cell collection efficiency present a significant opportunity in the Leukapheresis Market. Buyers increasingly prefer automated, closed systems that deliver consistent cell yields, reduce contamination risk, and standardize collection across sites. Continued innovation in cell separation accuracy and real-time monitoring is expected to widen adoption among blood centers and hospitals alike.
Emerging Market Trend: Growing Adoption of Leukapheresis in Cell-Based Therapies
A defining trend in the Leukapheresis Market is its expanding role in cell-based therapies, particularly CAR-T cell and stem cell research. Leukapheresis is a critical first step in T-cell harvesting, where leukopak specifications such as cell viability, composition, sterility, and storage conditions directly affect downstream manufacturing outcomes. Hospitals, research institutions, and biotech firms are increasingly relying on leukapheresis to support high-quality, personalized cell therapy production.
Market Challenge: High Procedural and Equipment Costs
High procedural and equipment costs remain a key challenge for the Leukapheresis Market. Leukapheresis systems and the specialized consumables required for cell collection represent a significant capital and operating expense for hospitals, blood centers, and research institutes. These costs can slow adoption of advanced apheresis platforms, particularly among smaller facilities and in cost-sensitive healthcare markets, even as demand for cell and gene therapy starting material continues to rise.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :
https://www.polarismarketresearch.com/industry-analysis/leukapheresis-market
How Is Market Segmentation Done?
The research gives an in-depth segmental analysis of the Leukapheresis Market industry. The segmentation in the market has been done on the basis of type (devices and disposables), leukopak (mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and PBMCs), indication (leukemia, lymphoma, and multiple myeloma), application (research and therapeutic), and end-use (blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies, and hospitals and transfusion centers). The devices segment held the largest share of the market in 2025, supported by rising adoption of therapeutic leukapheresis procedures and a growing number of blood collection centers using these systems. By application, research is expected to register the highest CAGR during the forecast period, driven by expanding cell and gene therapy pipelines and rising demand for PBMC and T-cell starting material, while the blood component providers and blood centers segment, by end-use, is anticipated to post the fastest growth on rising blood donations and expanding contract collection services for biopharma clients. This analysis helps stakeholders analyze evolving demand trends and recognize promising market opportunities.
Which Region Leads Market Demand?
The report includes a regional analysis of the Leukapheresis Market, covering North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market dominates the overall market, attributed to its robust healthcare infrastructure, a large population of leukemia patients, a high number of ongoing clinical trials for cell-based cancer therapies, early commercialization of cell and gene therapies, and favorable reimbursement and insurance coverage for advanced therapies. Further, the Asia Pacific market is expected to witness significant growth during the forecast period, influenced by an increasing number of cell therapy clinical trial sites, rising investment in cancer care, and expanding healthcare infrastructure, including the growth of blood centers. In addition to this, there is an analysis of regional demand, investments, infrastructure, regulatory environment, technology penetration, and industry development.
Who Are the Key Market Players?
The report presents a detailed competitive analysis of the Leukapheresis Market industry. Player positioning and their strategy, such as new product/service launches, partnerships, mergers and acquisitions, geographic expansion, capacity expansion, technological developments, etc., have been analyzed. The report also examines the competitive structure of the industry and how organizations are responding to changing consumer demands.
A few of the key players in the market include:
- AllCells, LLC
- StemExpress, LLC.
- Haemonetics Corporation
- Caltag Medsystems Limited
- Lonza Group AG
- ZenBio
- Asahi Kasei Medical
- Terumo BCT, Inc.
- Macopharma SA
- Miltenyi Biotec
- Fresenius SE & Co. KGaA
- Guangzhou Daji Medical Science
- MEDICA S.p.A
- PuriBlood Medical Co. Ltd.
- Beijing ZKSK Technology Co. Ltd.
Future Outlook
The Leukapheresis Market is projected to grow and evolve until the forecast year 2034 as demand grows, applications widen, and industry players respond to changing demands. Innovations, investments, and technological advancements are expected to drive market development and present new opportunities in major segments and geographies. This report provides insights into how the market is expected to evolve, thereby enabling stakeholders to understand opportunities and developments likely to shape the market during the forecast period.
More Trending Latest Reports By Polaris Market Research:
top-5-companies-transforming-electric-vehicle-ev-parts-and-components-market-in-2025
understanding-the-role-of-ignition-coils-in-modern-automotive-combustion
brain-machine-interface-market
customer-experience-management-market
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek